Looking At Amgen's Recent Unusual Options Activity

Someone with a lot of money to spend has taken a bullish stance on Amgen AMGN.

And retail traders should know.

We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Whether this is an institution or just a wealthy individual, we don't know. But when something this big happens with AMGN, it often means somebody knows something is about to happen.

So how do we know what this whale just did?

Today, Benzinga's options scanner spotted 12 uncommon options trades for Amgen.

This isn't normal.

The overall sentiment of these big-money traders is split between 58% bullish and 41%, bearish.

Out of all of the special options we uncovered, 4 are puts, for a total amount of $152,105, and 8 are calls, for a total amount of $306,759.

What's The Price Target?

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $220.0 to $235.0 for Amgen over the last 3 months.

Volume & Open Interest Development

Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.

This data can help you track the liquidity and interest for Amgen's options for a given strike price.

Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Amgen's whale activity within a strike price range from $220.0 to $235.0 in the last 30 days.

Amgen Option Volume And Open Interest Over Last 30 Days

Biggest Options Spotted:

Where Is Amgen Standing Right Now?

• With a volume of 902,173, the price of AMGN is down -1.27% at $231.18.
• RSI indicators hint that the underlying stock may be approaching overbought.
• Next earnings are expected to be released in 2 days.

What The Experts Say On Amgen:

• Credit Suisse has decided to maintain their Outperform rating on Amgen, which currently sits at a price target of $200.
• Oppenheimer downgraded its action to Outperform with a price target of $280
• Barclays has decided to maintain their Underweight rating on Amgen, which currently sits at a price target of $210.

Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.

If you want to stay updated on the latest options trades for Amgen, Benzinga Pro gives you real-time options trades alerts.